drugset / Trial / NCT07361367
A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants
Non-randomizedSequentialOpen-labelTreatment
Summary
The objective of this study is to evaluate the PK of a tablet formulation of ABBV-722 under fasted conditions and the effect of food on its bioavailability after administration of single doses
Timeline
- Start
- 2026-01-15
- Primary completion
- 2026-03-23
- Completion
- 2026-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABBV-722 | Unknown | — | Oral |
Indications
No indication recorded.